Details for New Drug Application (NDA): 207157
✉ Email this page to a colleague
The generic ingredient in LANSOPRAZOLE is amoxicillin; clarithromycin; lansoprazole. There are forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.
Summary for 207157
Tradename: | LANSOPRAZOLE |
Applicant: | Lannett Co Inc |
Ingredient: | lansoprazole |
Patents: | 0 |
Pharmacology for NDA: 207157
Mechanism of Action | Proton Pump Inhibitors |
Physiological Effect | Inhibition Gastric Acid Secretion |
Medical Subject Heading (MeSH) Categories for 207157
Suppliers and Packaging for NDA: 207157
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LANSOPRAZOLE | lansoprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 207157 | ANDA | Lannett Company, Inc. | 62175-515 | 62175-515-12 | 2 BOTTLE in 1 PACKAGE, COMBINATION (62175-515-12) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE |
LANSOPRAZOLE | lansoprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 207157 | ANDA | Lannett Company, Inc. | 62175-515 | 62175-515-24 | 1 BOTTLE in 1 CARTON (62175-515-24) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | 15MG | ||||
Approval Date: | Sep 29, 2017 | TE: | RLD: | No |
Complete Access Available with Subscription